New dye to help see brain tumors during surgery
Part of Cancer clinical trials.
This study tests a new dye called SBK2-ICG that helps surgeons see brain tumors more clearly during surgery. The dye is given before surgery and may help your doctor remove more of the tumor safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a brain tumor that is newly diagnosed and has not been treated yet.
- You are 18 years or older.
- You have a kind of brain tumor called a glioma (especially the type called grade IV or glioblastoma).
- You are willing and able to have surgery to remove the tumor.
- Your kidneys and liver are working well (your doctor will check this with blood tests).
- You can have an MRI scan (special imaging of the brain).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether a special dye called 5-ALA can help doctors see brain tumors more clearly during surgery. You may be able to join if you are scheduled for surgery to remove a suspected high-grade glioma.
This trial tests a new kind of PET scan that uses a special tracer (Zr-89 crefmirlimab berdoxam) to help doctors see brain tumors more clearly before surgery. If you are scheduled to have your brain tumor removed, this scan may give your surgeon extra information to guide the operation.
This trial tests a new drug called BI 764532 for people with a type of brain tumor called glioma that has not gotten better with standard treatments. The drug targets a protein on the tumor cells, which might help stop the tumor from growing.
This trial tests if a special dye attached to the immunotherapy drug nivolumab can help surgeons see tumor cells during surgery for high grade glioma. You may join if you are scheduled for surgery and your organs are working well.
This trial tests a special fluorescent dye (FG001) that helps surgeons see and remove high-grade brain tumors more completely during surgery. The dye is injected before surgery and glows under special light, potentially helping surgeons remove more tumor tissue safely.
This trial tests a device (CCeLL-In Vivo) that may help surgeons tell tumor from normal brain tissue during an operation, which could improve how much tumor is removed while protecting healthy brain.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.